The Project: Objectives
Key aspects of the PHEMS project include:
Federated Health Data Innovation
The project focuses on creating an open ecosystem model that leverages real-world data, algorithmically anonymized data, and synthetic data. This approach will enable cross-border collaboration with health data and the application of machine learning algorithms, while ensuring compliance with ethical, legal, and technical standards.
Clinical Use Cases
PHEMS is set to conduct studies on three key pediatric clinical use cases: managing cardiac patient pathways for children, predicting sepsis in pediatric intensive care, and treating hematology/hemophilia in young patients. These cases aim to enhance understanding in pediatric healthcare operations and confirm the effectiveness of synthesized and anonymized data in real-life pediatric settings.
Engagement and Accessibility
The project aims to understand the needs of data users and engage various stakeholders like hospitals, SMEs, researchers, industry, policy makers and the general public through webinars, hackathons, and online content. This effort is directed towards facilitating continuous engagement and making data access and usage more user-friendly.
Sustainable Business Model
A crucial objective of PHEMS is to create a business model and commercial plan that ensures a self-sustaining ecosystem that can continue to offer its health data management services, thereby making a lasting, positive impact on the lives of those it serves. This approach is rooted in the belief that the true measure of success lies in the project’s ability to maintain its operations and support long-term, demonstrating a commitment to ongoing assistance and care for its beneficiaries.
Innovative Ambitions
The consortium is set to be the first of its kind in pediatrics to implement a decentralized health data ecosystem, focusing on on-demand synthetic data services with exceptional accuracy and validity. This development is expected to significantly benefit data users in advancing disease diagnosis, treatment, epidemiology, and pharmacovigilance, ensuring full compliance with EU and national laws and regulations.